Drug Targeting by Diagnostic Ultrasound Contrast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Drug Targeting by Diagnostic Ultrasound Contrast
Microbubbles can temporarily open many biological barriers for polar molecules, macromolecules, and particles. Scientists have brought well-known contrast agents back to the laboratory and redesigned them as drug carriers.


Pharmaceutical Technology


References

1. C. Mayer and R. Bekeredjian, Adv. Drug Deliv. Rev. 60 (10), 1177–1192 (2008).

2. S. Tinkov et al., J. Pharm. Sci. 98 (6), 1935–1961 (2009).

3. P. Li, W.F. Armstrong, and D.L. Miller, Ultrasound Med. Biol. 30 (1), 83–91 (2004).

4. J. Song et al., J. Am. Coll. Cardiol. 39 (4), 726–731 (2002).

5. M.A. Borden et al., Langmuir 23 (18), 9401–9408 (2007).

6. R. Bekeredjian et al., Circulation 108,1022–1026 (2003).

7. R. Bekeredjian et al., Ultrasound Med. Biol. 31 (5), 687–691 (2005).

8. S. Tinkov et al., J. Control. Release 143 (1), 143–150 (2010).

9. J. Kang, J. Ultrasound Med. 29 (1), 61–70 (2010).

10. E.C. Unger et al., Acad. Radiol. 5 (10), 247–249 (1998).

11. M.S. Tartis et al., Ultrasound Med. Biol. 32 (11), 1771–1780 (2006).

12. J.Y. Fang et al., Eur. J. Pharm. Biopharm. 67 (1), 67–75 (2007).

13. S. Tinkov, Development of Ultrasound Contrast Agents for Targeted Drug and Gene Delivery (Verlag Dr. Hut, Munich, 2009).

14. I. Lentacker, "Design and Evaluation of Drug-Loaded Microbubbles for Ultrasound-Guided Cancer Therapy. Faculty of Pharmaceutical Sciences" (PhD diss., Ghent University, 2009), 216.

15. I. Lentacker et al., Mol. Ther. 18 (1), 101–108 (2010).

16. L.H. Treat et al., Int. J.Cancer 121 (4), 901–907 (2007).

17. R.K. Schlicher et al., Ultrasound Med. Biol. 32 (6), 915–924 (2006).

18. J.R. Eisenbrey et al., J. Control. Release 143 (1), 38–44 (2010).

19. N. Rapoport, Z. Gao, and A. Kennedy, J. Natl. Cancer Inst. 99 (14), 1095–1106 (2007).

20. J.J. Choi, "Noninvasive, Localized, and Transient Brain Drug Delivery Using Focused Ultrasound and Microbubbles" (PhD diss., University of Columbia, 2010), 170.

21. E.E. Konofagou et al., AIP Conference Proceedings (Aix-en-Provence, France, 2010), pp. 172–175.

22. J.M. Erikson, G.L. Freeman, and B. Chandrasekar, J. Mol. Cell. Cardiol. 35 (1), 119–130 (2003).

23. E. Akowuah et al., Gene Ther. 12 (14), 1154–1157 (2005).

24. T.R. Porter et al., Ultrasound Med. Biol. 27 (2), 259–265 (2001).

25. X. Feng et al., Ultrasound Med. Biol. 31 (7), 979–985 (2005).

26. F.M. Asch and N.J. Weissman, Circulation 119 (14), 1956–1961 (2009).

27. S. Seemann et al., Pharm. Res. 19 (3), 250–257 (2002).

28. K. Kooiman et al., J. Control. Release 133 (2), 109–118 (2009).

29. A. Kheirolomoom et al., J. Control. Release 118 (3), 275–284 (2007).

30. M.L. Fabiilli, Ultrasound Medicine Biol. 36 (8), 1364–1375 (2010).

31. K.H. Nam et al., AIP Conference Proceedings (Aix-en-Provence France, 2009), pp. 124–128.

32. S.L. Huang and R.C. MacDonald, Biochim. Biophys. Acta 1665 (1–2), 134–141 (2004).

33. S. Tinkov et al., J. Pharm. Sci. 98 (6), 1935–1961 (2009).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here